Pages that link to "Q38881484"

The following pages link to Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial (Q38881484):

Displaying 47 items.

• Artemisinin-based combination therapy for treating uncomplicated malaria (Q24241785) (← links)
• Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda (Q24815752) (← links)
• Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum (Q28469026) (← links)
• Cost-effectiveness study of three antimalarial drug combinations in Tanzania (Q28469054) (← links)
• Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania (Q28475232) (← links)
• An economic evaluation of home management of malaria in Uganda: an interactive Markov model (Q28475337) (← links)
• Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts (Q30226671) (← links)
• Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials (Q30567158) (← links)
• The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data (Q30936416) (← links)
• Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda (Q33251914) (← links)
• Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria (Q33385477) (← links)
• Malaria: uncomplicated, caused by Plasmodium falciparum. (Q33446846) (← links)
• Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children (Q33650896) (← links)
• An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia (Q33678775) (← links)
• Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool (Q33875677) (← links)
• Cost effectiveness analysis of strategies to combat malaria in developing countries. (Q34165448) (← links)
• Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination (Q34177472) (← links)
• Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial (Q34413590) (← links)
• Pharmacovigilance of antimalarial treatment in Africa: is it possible? (Q34872414) (← links)
• Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults (Q35053376) (← links)
• Malaria treatment policy change and implementation: the case of Uganda (Q35692263) (← links)
• Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar (Q35834329) (← links)
• Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda (Q35912645) (← links)
• Malaria in Uganda: challenges to control on the long road to elimination. II. The path forward (Q36226231) (← links)
• Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for uncomplicated malaria: a systematic review (Q36505813) (← links)
• Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda (Q36766577) (← links)
• Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children (Q36855449) (← links)
• Malaria case-management under artemether-lumefantrine treatment policy in Uganda (Q36916127) (← links)
• Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali (Q37074386) (← links)
• The effect of varying analytical methods on estimates of anti-malarial clinical efficacy (Q37184291) (← links)
• Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance (Q37323427) (← links)
• Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis (Q37350167) (← links)
• Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda (Q37436582) (← links)
• Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009 (Q37703517) (← links)
• Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial (Q38399521) (← links)
• Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial (Q39284402) (← links)
• Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone (Q40308948) (← links)
• Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. (Q40469006) (← links)
• Antimalarial treatment with artemisinin combination therapy in Africa (Q42548302) (← links)
• Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa (Q43932822) (← links)
• Analysing malaria drug trials on a per-individual or per-clone basis: a comparison of methods (Q46865781) (← links)
• The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan (Q46897582) (← links)
• Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis (Q48035625) (← links)
• Malaria (Q55878749) (← links)
• A Mathematical Model for the Transmission and Spread of Drug Sensitive and Resistant Malaria Strains within a Human Population (Q59048091) (← links)
• Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study (Q60913720) (← links)
• Poor-quality antimalarials further health inequities in Uganda (Q91801477) (← links)